For Sensible Investors, The Worst Performing Mag 7 Should Be a No-Brainer
Tesla sits at the bottom of the Magnificent 7 leaderboard while trading at a valuation that leaves almost no room for error, and the latest earnings report raises serious questions about whether the spending cycle can ever pay off.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Tesla (NASDAQ:TSLA | TSLA Price Prediction) trades at $370.59 as the worst-performing Magnificent 7 stock, with a valuation that leaves little room for error. Shares just rose 4.65% in a single session after better-than-expected vehicle deliveries, which puts fresh focus on whether earnings can catch up to the stock.
Tesla still generates most of its revenue from electric vehicles and energy storage. Management, however, is spending heavily to turn it into an autonomy, robotics and AI chip company. The stock is down 17.6% year to date. Over the same stretch, NVIDIA (NASDAQ:NVDA) gained 25.74% and Apple (NASDAQ:AAPL) added 23.08%.
Record Deliveries and Robotaxi Momentum Power the Bull Case
Second-quarter deliveries reached a record 480,126. Revenue rose 25.52% to $28.24 billion, beating estimates by 7.1%. Active FSD subscriptions climbed 56% to 1.48 million, and Robotaxi now operates in seven U.S. metros.
Energy storage deployments grew 41% to 13.5 GWh. Bulls also point to $43.524 billion in cash and a debt-to-equity ratio of just 0.10, which together pay for the expansion without strain.
A 346x Multiple Meets Collapsing Margins
The operating margin fell to 1.4% and operating income dropped 56.88%. EPS came in at $0.33, missing expectations by 38.51%. Free cash flow turned negative at -$1.092 billion after capex rose 141.81%.
Management expects 2026 capex of “more than $25 billion” and says spending will keep growing for “the next two or three years.” Net income also got help from a $1 billion mark-to-market gain on SpaceX holdings, so the quarter was weaker than the reported profit suggests.
Execution Over the Next Two Quarters Could Reshape the Outlook
Tesla left the second quarter with its “largest order backlog since 2023”, and the latest deliveries beat forecasts. Earnings power is the open question. If the next two earnings reports show operating margins recovering and Cybercab volume increasing, the bull case gets stronger.
Wall Street Sees Thin Upside as the S&P 500 Pulls Away
The consensus target of $395.57 means about 6.7% upside from the current price. That target comes from 43 analysts, and targets are estimates that can change. The ratings break down this way:
- Strong Buy: 4
- Buy: 15
- Hold: 20
- Sell: 2
- Strong Sell: 2
Tesla trades at 346 times trailing earnings and 159 times forward earnings, with a PEG ratio of 4.54. Year to date, the stock is down 17.6% while the S&P 500 is up 12.86%. Over one year, Tesla fell 15% and the index gained 15.01%. Multiples like these only work if the mania keeps running, and we laid out how to ride one without getting trapped in a free bubble handbook.
Tesla’s Valuation Hinges on the Spending Cycle Paying Off
At $370.59, Tesla faces several challenges.
The path to more downside runs through cash flow. Tesla expects capex to rise further in the second half of 2026 and is lining up debt capacity of up to $30 billion. That points to more quarters of thin margins and weak free cash flow. A multiple above 300x leaves no room for either.
The risk/reward looks uneven. The consensus target offers single-digit upside. Nearly half of covering analysts rate the stock a Hold. The recent jump on deliveries also does nothing about the earnings gap. The latest delivery beat came alongside a falling operating margin.
Two developments would change this outlook: operating margins climbing back toward Q1’s GAAP operating income of $941 million, and Robotaxi or Optimus starting to produce reported revenue. Watch the next earnings report for both.
Tesla is pricing in a future it has not yet funded, and that leaves little margin for error at $370.59.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
